Media

Oncopeptides will host a Webcast on Monday, 17 June at 09:00 (CET) to review and update presentations from European Hematology (EHA) meeting

Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference

Altimmune Appoints Will Brown as Chief Financial Officer

Altimmune Announces Successful Pre-IND Meeting with FDA

Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

Strongbridge Biopharma plc Strengthens Senior Leadership Team with Key Promotion and Appointment

New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting

Carisma Therapeutics Names Dr. Robert Petit as Chief Scientific Officer

Nordic Nanovector: European patent granted for Betalutin® or Humalutin® in combination with anti-CD20 antibodies for treating NHL